Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Animal rights attacks were terrorism not activism, says Vasella

August 13, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
News

AZ signs antibiotic deal with Forest Laboratories

August 13, 2009 Research and Development, Sales and Marketing Antibiotics, Forest

AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …
News

Authorised generics deals likely here to stay, says analyst

August 12, 2009 Research and Development, Sales and Marketing generics

The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …
News

EMEA makes adverse drug reaction research a priority

August 12, 2009 Research and Development, Sales and Marketing Europe, drug safety

Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …
News

New FDA head aims for aggressive enforcement

August 11, 2009 Research and Development, Sales and Marketing FDA, US, drug safety

The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …
News

Skills council for pharma

August 11, 2009 Research and Development, Sales and Marketing Jobs, training

The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …
News

Contract research news in brief

August 11, 2009 Research and Development CRO, Omnicom

Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Pharm-Olam, OmniComm, SIRO, Ecron Acunova …
News

Charles River cuts forecasts as profits slump

August 11, 2009 Research and Development Charles River, preclinical

Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …
News

Sanofi submits FDA application for swine flu vaccine

August 10, 2009 Research and Development, Sales and Marketing Sanofi-Aventis, h1n1

Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …
News

Doubts about funding for ‘Innovation Pass’

August 10, 2009 Research and Development, Sales and Marketing ABPI, NHS, NICE

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
News

TNF blockers must carry children’s cancer warning

August 7, 2009 Research and Development, Sales and Marketing FDA, RA, TNF

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …
News

Vernalis and GSK sign risk-sharing deal

August 7, 2009 Research and Development, Sales and Marketing Deals, GSK, Vernalis

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
News

Pfizer agrees price cut in Clinton deal

August 7, 2009 Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …
News

Quintiles opens Ghana office

August 7, 2009 Research and Development Africa, Quintiles

Quintiles has opened a new office in Accra, Ghana, which it says will increase capacity to manage clinical studies for …
News
GSKfluvaccine

Racing to save lives and fighting the PR battle

August 6, 2009 Medical Communications, Research and Development Vaccine, clinical trials, public relations

Vaccine companies are working round the clock to develop and manufacture a vaccine for the H1N1 pandemic flu, and are …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025